Bladder & Renal Group

The NCRI Bladder & Renal Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of bladder and renal cancer. The Group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for bladder and renal cancer patients.

The NCRI Bladder & Renal Group consists of an executive Group, chaired by Professor Robert Jones, which provides oversight of the research landscape and proactively identifies opportunities for the Group. The NCRI Bladder & Renal Group also has several subgroups that develop research in areas of strategic need. Members are competitively recruited to the executive Group and subgroups twice a year.

The NCRI Bladder & Renal Group was formed when the NCRI Bladder Group and NCRI Renal Group merged in 2015.

Group Chair: Professor Robert Jones, Medical Oncologist, Glasgow

Axel Bex, Consultant Clinical Lead Renal Cancer, Royal Free London NHS Foundation Trust

Christopher Blick, Consultant Urological Surgeon, University of Oxford

James Catto, Professor & Clinical Scientist, University of Sheffield

Simon Crabb, Associate Professor of Medical Oncology & Consultant in Medical Oncology, University of Southampton

Alison Fielding, NCRI Consumer Forum Member, Kidney Cancer Support Network

Kate Fife, Consultant Clinical Oncologist, Addenbrooke’s Hospital NHS Foundation Trust

Emma Hall, Deputy Director, Institute of Cancer Research (ICR)

Ann Henry, Associate Professor in Clinical Oncology, Leeds Teaching Hospitals NHS Trust

Peter Hoskin, Professor of Clinical Oncology, Mount Vernon Cancer Centre

Arabella Hunt, Clinical Research Fellow, Institute of Cancer Research (ICR)

Syed Hussain, Consultant in Medical Oncology, University of Sheffield

Robert Jones, Professor of Clinical Cancer Research and Honorary Consultant In Medical Oncology, University of Glasgow

Vincent Khoo, Consultant Clinical Oncologist, Royal Marsden NHS Foundation Trust

Param Mariappan, Western General Hospital

Salena Mulhere

David Nicol, Consultant Urologist & Chief of Surgery, Royal Marsden NHS Foundation Trust

Hardev Singh Pandha, Consultant Medical Oncologist, University of Surrey

Lisa Pickering, Consultant Medical Oncologist, St George’s University Hospitals NHS Trust

Manon Pillai, Medical Oncology Specialist Trainee, Christie NHS Foundation Trust

Henry Scowcroft, Communications Strategy Lead, Cancer Research UK (CRUK)

Samra Turajlic, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust

Tom Waddell, Consultant in Medical Oncology, Christie NHS Foundation Trust

Anne Warren, Consultant Histopathologist, Cambridge University Hospitals NHS Foundation Trust

More from NCRI